(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

BIOARCH

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

BIOARCH

ST13

US500000077210412

Class

10

Filing

77210412

Registration

3474925

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

33

Latest update

01/13/2021

Trademark type

Word

Nice classes

10

Filing date

06/20/2007

Registration date

07/29/2008

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/10/2019

Last transaction

01/13/2021

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

06/04/2007

First use in commerce

06/04/2007

Drawing code

4

Owner type

03

Owner location

Memphis, TN

Examiner

MEIER, SHARON

Law office

M30

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

WRIGHT MEDICAL TECHNOLOGY, INC.
WRIGHT MEDICAL TECHNOLOGY, INC.
Koby Ventures, L.P.

Representatives

Thomas M. Palisi LERNER DAVID LITTENBERG KRUMHOLZ & MENTLIK, LLP

Technical classification

Nice Classes

Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 10

Medical instruments and surgical implants comprising artificial material for surgical procedures of the lower extremity including subtalar implantationsurgical implants comprising artificial material and kits containing trial sizers probesdrivers and removal tools

Publications

History of USPTO decisions and trademark events.

33 publications found

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

01/13/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/13/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

01/13/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

01/13/2021

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

01/13/2021

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

02/10/2019

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

02/10/2019

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

02/10/2019

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

02/09/2019

E89R

TEAS SECTION 8 & 9 RECEIVED

01/11/2019

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

07/29/2017

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

08/14/2014

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

08/14/2014

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/13/2014

E815

TEAS SECTION 8 & 15 RECEIVED

07/29/2014

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/05/2013

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/05/2013

R.PR

REGISTERED-PRINCIPAL REGISTER

07/29/2008

PUBO

PUBLISHED FOR OPPOSITION

05/13/2008

NPUB

NOTICE OF PUBLICATION

04/23/2008

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/16/2008

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/16/2008

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

04/07/2008

ALIE

ASSIGNED TO LIE

04/07/2008

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/27/2008

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

03/26/2008

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/24/2008

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/24/2008

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/24/2008

CNRT

NON-FINAL ACTION MAILED

09/25/2007

CNRT

NON-FINAL ACTION WRITTEN

09/24/2007

DOCK

ASSIGNED TO EXAMINER

09/23/2007

NWAP

NEW APPLICATION ENTERED

06/25/2007

Continuous trademark protection

Get notified about every new filing that threatens BIOARCH or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.